Modulating inhibitory ligand-gated ion channels

AAPS Journal

Volumn 8, Issue 2, 2006, Pages

  Cascio, Michael ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetics; GABAA receptor; Glycine receptor; Nicotinicoid; Therapeutics

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ALFAXALONE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CHOLESTEROL; COCAINE; GLYCINE RECEPTOR; ION CHANNEL; MEMBRANE PROTEIN; NEUROSTEROID; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; PHENOBARBITAL; POTASSIUM CHANNEL; PREGNENOLONE; PROSTAGLANDIN E2; PROTEIN KINASE C; SODIUM CHANNEL;

ALCOHOLISM; ALLOSTERISM; ANALGESIA; ANTICONVULSANT ACTIVITY; BINDING SITE; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CORRELATION ANALYSIS; DEPRESSION; DRUG TARGETING; EPILEPSY; HUMAN; HYPNOSIS; INHIBITION KINETICS; MACROMOLECULE; MENTAL DISEASE; MOOD DISORDER; NERVE CELL; NEUROLOGIC DISEASE; NOCICEPTION; PATHOPHYSIOLOGY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RESPIRATION DEPRESSION; REVIEW; SEDATION; TRANQUILIZING ACTIVITY;

ALCOHOLS; ANESTHETICS; BARBITURATES; ION CHANNEL GATING; ION CHANNELS; LIGANDS; LIPIDS; RECEPTORS, GABA; RECEPTORS, GLYCINE; RECEPTORS, NICOTINIC; STEROIDS;

EID: 33744904226     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj080240     Document Type: Review

References (141)

1. Karlin A, Akabas MH. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 1995;15:1231-1244.
2. Cascio M. Structure and function of the glycine receptor and related nicotinicoid receptors. J Biol Chem. 2004;279:19383-19386.
3. Brejc K, van Dijk WJ, Klaasen RV, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 2001;411:269-276.
4. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. J Mol Biol. 2005;346:967-989.
5. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002;3:102-114.
6. Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev. 2004;84:1051-1095.
7. Bowery NG, Smart TG. GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol. 2006;147:S109-S119.
8. Todd AJ, Watt C, Spike RC, Sieghart W. Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J Neurosci. 1996;16:974-982.
9. Jonas P, Bischofberger J, Sandkuhler J. Corelease of two fast neurotransmitters at a central synapse. Science. 1998;281:419-424.
10. O'Brien JA, Berger AJ. Cotransmission of GABA and glycine to brain stem motoneurons. J Neurophysiol. 1999;82:1638-1641.
11. Russier M, Kopysova IL, Ankri N, Ferrand N, Debanne D. GABA and glycine co-release optimizes functional inhibition in rat brainstem motoneurons in vitro. J Physiol. 2002;541:123-137.
12. Young TL, Cepko CL. A role for ligand-gated ion channels in rod photoreceptor development. Neuron. 2004;41:867-879.
13. Stein V, Nicoll RA. GABA generates excitement. Neuron. 2003;37:375-378.
14. Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728-739.
15. Kim G, Kandler K. Elimination and strengthening of glycinergic/GABAergic connections during tonotopic map formation. Nat Neurosci. 2003;6:282-290.
16. Li M, Lester HA. Ion channel diseases of the central nervous system. CNS Drug Rev. 2001;7:214-240.
17. Gundlach AL. Disorder of the inhibitory glycine receptor: inherited myoclonus in Poll Hereford calves. FASEB J. 1990;4:2761-2766.
18. Becker C-M, Schmieden V, Tarroni P, Strasser U, Betz H. Isoform-selective deficit of glycine receptors in the mouse mutant spastic. Neuron. 1992;8:283-289.
19. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet. 1993;5:351-358.
20. A receptor function and pharmacology in epilepsy and status epilepticus. Curr Opin Pharmacol. 2003;3:12-18.
21. Wong CG, 3rd, Bottiglieri T, 3rd, Snead OC, 3rd. GABA, γ-hydroxybutyric acid, and neurological disease. Ann Neurol. 2003; 54:S3-12.
22. Pfeiffer F, Graham D, Betz H. Purification by affinity chromatography of the glycine receptor of rat spinal cord. J Biol Chem. 1982;257:9389-9393.
23. Grudzinska J, Schemm R, Haeger S, et al. The β subunit determines the ligand binding properties of synaptic glycine receptors. Neuron. 2005;45:727-739.
24. Donizelli M, Djite MA, Le Novere N. LGICdb: a manually curated sequence database after the genomes. Nucleic Acids Res. 2006;34:D267-D269.
25. A receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol. 1998;18:35-86.
26. Sine SM, Wang HL, Bren N. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain. J Biol Chem. 2002;277:29210-29223.
27. Bouzat C, Gumilar F, Spitzmaul G, et al. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature. 2004;430:896-900.
28. A receptor structure relieved by AChBP. Trends Biochem Sci. 2002;27:280-287.
29. Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA. Asymmetric structural motions of the homomeric α7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys J. 2003;85:3007-3018.
30. Nevin ST, Cromer BA, Haddrill JL, Morton CJ, Parker MW, Lynch JW. Insights into the structural basis for zinc inhibition of the glycine receptor. J Biol Chem. 2003;278:28985-28992.
31. Absalom NL, Lewis TM, Kaplan W, Pierce KD, Schofield PR. Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor. J Biol Chem. 2003;278:50151-50157.
32. 3 receptor: a model ligand-gated ion channel. Mol Membr Biol. 2002;19:11-26.
33. Grutter T, Prado de Carvalho L, Virginie D, Taly A, Fischer M, Changeux JP. A chimera encoding the fusion of an acetylcholine-binding protein to an ion channel is stabilized in a state close to the desensitized form of ligand-gated ion channels. C R Biol. 2005;328:223-234.
34. Horikoshi T, Asanuma A, Yanagisawa K, Anzai K, Goto S. Taurine and β-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA. Brain Res. 1988;464:97-105.
35. Wafford KA, Ebert B. Gaboxadol - a new awakening in sleep. Curr Opin Pharmacol. 2006;6:30-36.
36. Schmieden V, Kuhse J, Betz H. Mutation of glycine receptor subunit creates β-alanine receptor responsive to GABA. Science. 1993;262:256-258.
37. 2+. Mol Pharmacol. 1994;46:1156-1159.
38. Lynch JW, Jacques P, Pierce KD, Schofield PR. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways. J Neurochem. 1998;71:2159-2168.
39. Miller PS, Da Silva HM, Smart TG. Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors. J Biol Chem. 2005;280:37877-37884.
40. A receptors: discrete binding sites underlie subtype specificity. Nat Neurosci. 2003;6:362-369.
41. Chen Z, Dillon GH, Huang R. Molecular determinants of proton modulation of glycine receptors. J Biol Chem. 2004;279:876-883.
42. A receptors. J Neurosci. 2002;22:5328-5333.
43. A receptors: influence of GABA concentration and the beta subunit TM2-TM3 domain. J Physiol. 2005;567:365-377.
44. Miyazawa A, Fujiyoshi Y, Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature. 2003;423:949-955.
45. Auerbach A. Gating of acetylcholine receptor channels: Brownian motion across a broad transition state. Proc Natl Acad Sci USA. 2005;102:1408-1412.
46. Lummis SC, Beene DL, Lee LW, Lester HA, Broadhurst RW, Dougherty DA. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature. 2005;438:248-252.
47. Xiu X, Hanek AP, Wang J, Lester HA, Dougherty DA. A unified view of the role of electrostatic interactions in modulating the gating of cys loop receptors. J Biol Chem. 2005;280:41655-41666.
48. Paas Y, Gibor G, Grailhe R, et al. Pore conformations and gating mechanism of a cys-loop receptor. Proc Natl Acad Sci USA. 2005;102:15877-15882.
49. Tang P, Mandal PK, Xu Y. NMR structures of the second transmembrane domain of the human glycine receptor α1 subunit: model of pore architecture and channel gating. Biophys J. 2002;83:252-262.
50. A receptor. Biochem Soc Trans. 2004;32:540-546.
51. A receptor. Nature. 2003;421:272-275.
52. Schofield CM, Jenkins A, Harrison NL. A highly conserved aspartic acid residue in the signature disulfide loop of the α1 subunit is a determinant of gating in the glycine receptor. J Biol Chem. 2003;278:34079-34083.
53. Schofield CM, Trudell JR, Harrison NL. Alanine-scanning mutagenesis in the signature disulfide loop of the glycine receptor α1 subunit: critical residues for activation and modulation. Biochemistry. 2004;43:10058-10063.
54. A receptor: three residues are required for allosteric coupling. J Neurosci. 1999; 19:10213-10220.
55. Tasneem A, Iyer LM, Jakobsson E, Aravind L. Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol. 2005;6:R4.
56. Changeux J, Edelstein SJ. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors. Curr Opin Neurobiol. 2001;11:369-377.
57. Williams DB, Akabas MH. γ-aminobutyric acid increases the water accessibility of M3 membrane-spanning segment residues in γ-aminobutyric acid type A receptors. Biophys J. 1999;77:2563-2574.
58. Williams DB, Akabas MH. Benzodiazepines induce a conformational change in the region of the γ-aminobutyric acid type A receptor α1-subunit M3 membrane-spanning segment. Mol Pharmacol. 2000; 58:1129-1136.
59. A receptor pore-lining M2 segment. Nat Neurosci. 2001;4:477-485.
60. A receptor M2-M3 loop secondary structure and changes in accessibility during channel gating. J Biol Chem. 2002;277:43002-43010.
61. A receptor α and β subunit channel-lining segments. J Biol Chem. 2005;280:1573-1581.
62. Lynch JW, Han NL, Haddrill J, Pierce KD, Schofield PR. The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state. J Neurosci. 2001;21:2589-2599.
63. A receptors. J Biol Chem. 2002;277:44845-44853.
64. Hawthorne R, Lynch JW. A picrotoxin-specific conformational change in the glycine receptor M2-M3 loop. J Biol Chem. 2005;280:35836-35843.
65. Lobo IA, Mascia MP, Trudell JR, Harris RA. Channel gating of the glycine receptor changes accessibility to residues implicated in receptor potentiation by alcohols and anesthetics. J Biol Chem. 2004;279:33919-33927.
66. Lobo IA, Trudell JR, Harris RA. Accessibility to residues in transmembrane segment four of the glycine receptor. Neuropharmacology. 2006;50:174-181.
67. A receptor M2 channel-lining segments. J Biol Chem. 2005;280:35506-35512.
68. Han NL, Clements JD, Lynch JW. Comparison of taurine- and glycine-induced conformational changes in the M2-M3 domain of the glycine receptor. J Biol Chem. 2004;279:19559-19565.
69. Chang Y, Weiss DS. Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism. Nat Neurosci. 2002;5:1163-1168.
70. Lee AG. Lipid-protein interactions in biological membranes: a structural perspective. Biochim Biophys Acta. 2003;1612:1-40.
71. Anderson RG, Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science. 2002;296:1821-1825.
72. Tillman T, Cascio M. Effects of membrane lipids on ion channel structure and function. Cell Biochem Biophys. 2003;38:161-190.
73. Cascio M. Connexins and their environment: effects of lipids composition on ion channels. Biochim Biophys Acta. 2005;1711:142-153.
74. Barrantes FJ. Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res Brain Res Rev. 2004;47:71-95.
75. Baenziger JE, Morris M-L, Darsaut TE, Ryan SE. Effect of membrane lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor. J Biol Chem. 2000;275:777-784.
76. daCosta CJ, Ogrel AA, McCardy EA, Blanton MP, Baenziger JE. Lipid-protein interactions at the nicotinic acetylcholine receptor. A functional coupling between nicotinic receptors and phosphatidic acid-containing lipid bilayers. J Biol Chem. 2002;277:201-208.
77. daCosta CJ, Wagg ID, McKay ME, Baenziger JE. Phosphatidic acid and phosphatidylserine have distinct structural and functional interactions with the nicotinic acetylcholine receptor. J Biol Chem. 2004;279:14967-14974.
78. Blanton MP, Cohen JB. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry. 1994;33:2859-2872.
79. 125I]TIDPC/16. Biochemistry. 1998;37:14545-14555.
80. Leite JF, Blanton MP, Shahgholi M, Dougherty DA, Lester HA. Conformation-dependent hydrophobic photolabeling of the nicotinic receptor: electrophysiology-coordinated photochemistry and mass spectrometry. Proc Natl Acad Sci USA. 2003;100:13054-13059.
81. Hamouda AK, Chiara DC, Sauls D, Cohen JB, Blanton MP. Cholesterol interacts with transmembrane α-helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine receptor: photolabeling studies using [(3)h]azicholesterol. Biochemistry. 2006;45:976-986.
82. Barrantes FJ, Antollini SS, Blanton MP, Prieto M. Topography of nicotinic acetylcholine receptor membrane-embedded domains. J Biol Chem. 2000;275:37333-37339.
83. Mantipragada SB, Horvath LI, Arias HR, et al. Lipid-protein interactions and effect of local anesthetics in acetylcholine receptor-rich membranes from Torpedo marmorata electric organ. Biochemistry. 2003;42:9167-9175.
84. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 2005;438:612-621.
85. 125I]azido-cholesterol. Biochim Biophys Acta. 1998; 1414:65-74.
86. Jones OT, McNamee MG. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 1988;27:2364-2374.
87. Addona GH, Sandermann HJ, Kloczewiak MA, Husain SS, Miller KW. Where does cholesterol act during activation of the nicotinic acetylcholine receptor? Biochim Biophys Acta. 1998;1370:299-309.
88. Laube B. Membrane cholesterol affects the pharmacology of the recombinant inhibitory glycine receptor. 33rd Society for Neuroscience Annual Meeting Neurobiology of Lipids Sessions. Neurobiol Lipids. 2003; Available at: http://neurobiologyoflipids.org/content/2/3/.
89. A receptor by neuroactive steroids and other potentiators. Br J Pharmacol. 2001;134:1303-1311.
90. A receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology. 2001;40:178-184.
91. 1-glycine receptors. J Biol Chem. 2001;276:20981-20988.
92. Cantor RS. Lipid composition and the lateral pressure profile in bilayers. Biophys J. 1999;76:2625-2639.
93. Cantor RS. Receptor desensitization by neurotransmitters in membranes: are neurotransmitters the endogenous anesthetics? Biochemistry. 2003;42:11891-11897.
94. Trudell JR, Bertaccini E. Molecular modeling of specific and non-specific anaesthetic interactions. Br J Anaesth. 2002;89:32-40.
95. Miller KW. The nature of sites of general anaesthetic action. Br J Anaesth. 2002;89:17-31.
96. Yamakura T, Bertaccini E, Trudell JR, Harris RA. Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51.
97. Hemmings HC, Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci. 2005;26:503-510.
98. A receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol. 2000;57:1199-1205.
99. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature. 1997;389:385-389.
100. Mascia MP, Trudell JR, Harris RA. Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc Natl Acad Sci USA. 2000;97:9305-9310.
101. Lobo IA, Harris RA. Sites of alcohol and volatile anesthetic action on glycine receptors. Int Rev Neurobiol. 2005;65:53-87.
102. A receptor α1 subunit during channel gating and alcohol modulation. J Biol Chem. 2005;280:308-316.
103. Jung S, Harris RA. Sites in TM2 and 3 are critical for alcohol-induced conformational changes in GABA receptors. J Neurochem. 2006;96:885-892.
104. A receptor alpha1 subunit: implications for modulation by inhaled anesthetics and ion channel structure. Neuropharmacology. 2002;43:669-678.
105. A receptor. Nat Rev Neurosci. 2005;6:565-575.
106. A receptor at sites on the N-terminal side of the middle of TM2. Neuroreport. 1998;9:379-383.
107. A receptor β2 subunit affects allosteric sensitivity to GABA and anesthetics. Mol Pharmacol. 2000;57:474-484.
108. Maksay G, Laube B, Betz H. Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology. 2001;41:369-376.
109. Eser D, Romeo E, Baghai TC, et al. Neuroactive steroids as modulators of depression and anxiety. Neuroscience. 2006;138:1041-1048.
110. Belelli D, Herd MB, Mitchell EA, et al. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience. 2006;138:821-829.
111. Soderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res. 2000;113:85-96.
112. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci. 2004;5:55-65.
113. Malcolm RJ. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry. 2003;64:36-40.
114. A receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci. 2003;28:263-274.
115. Molander A, Lof E, Stomberg R, Ericson M, Soderpalm B. Involvement of accumbal glycine receptors in the regulation of voluntary ethanol intake in the rat. Alcohol Clin Exp Res. 2005;29:38-45.
116. Molander A, Soderpalm B. Accumbal strychnine-sensitive glycine receptors: an access point for ethanol to the brain reward system. Alcohol Clin Exp Res. 2005;29:27-37.
117. Ye JH, Tao L, Ren J, et al. Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. J Pharmacol Exp Ther. 2001;296:77-83.
118. - current of acutely dissociated rat hippocampal neurons. Eur J Pharmacol. 1999;367:125-130.
119. Beckstead MJ, 2nd, Weiner JL, 2nd, Eger EI, 2nd, Gong DH, Mihic SJ. Glycine and γ-aminobutyric acid receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol. 2000;57:1199-1205.
120. Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006;6:7-17.
121. Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5:553-564.
122. Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol Life Sci. 2006;63:399-413.
123. A receptors: relative orientation of ligands and amino acid side chains. Mol Pharmacol. 1998;54:1097-1105.
124. Haefely W, Kulcsar A, Mohler H. Possible involvement of GABA in the central actions of benzodiazepines. Psychopharmacol Bull. 1975;11:58-59.
125. A receptor investigated by a laser-pulse photolysis technique. Biochemistry. 2005;44:8523-8532.
126. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci. 2001;58:760-793.
127. A receptors and gephyrin. J Neurosci. 2005; 25:594-603.
128. Huang ZJ. Subcellular organization of GABAergic synapses: role of ankyrins and L1 cell adhesion molecules. Nat Neurosci. 2006;9:163-166.
129. Sola M, Bavro VN, Timmins J, et al. Structural basis of dynamic glycine receptor clustering by gephyrin. EMBO J. 2004;23:2510-2519.
130. Yevenes GE, Peoples RW, Tapia JC, et al. Modulation of glycine-activated ion channel function by G-protein βγ subunits. Nat Neurosci. 2003;6:819-824.
131. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB. Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors. Nature. 2000;403:274-280.
132. A receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther. 2004;102:195-221.
133. Collingridge GL, Isaac JT, Wang YT. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci. 2004;5:952-962.
134. Vaello M-L, Ruiz-Gómez A, Lerma J, Mayor FJ. Modulation of inhibitory glycine receptors by phosphorylation by protein kinase C and cAMP-dependent protein kinase. J Biol Chem. 1994;269:2002-2008.
135. 1β glycine receptors. J Physiol. 2002;539:495-502.
136. A receptors. Cell Mol Life Sci. 2005;62:119-127.
137. Gentet LJ, Clements JD. Binding site stoichiometry and the effects of phosphorylation on human α1 homomeric glycine receptors. J Physiol. 2002;544:97-106.
138. 2-mediated inflammatory pain sensitization. Science. 2004;304:884-887.
139. Lynch JW, Callister RJ. Glycine receptors: a new therapeutic target in pain pathways. Curr Opin Investig Drugs. 2006;7:48-53.
140. Laube B, Maksay G, Schemm R, Betz H. Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol Sci. 2002;23:519-527.
141. Birch PJ, Dekker LV, James IF, Southan A, Cronk D. Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain. Drug Discov Today. 2004;9:410-418.